JPRN-UMIN000013716已完成2 期
A study of infliximab administration method for tacrolimus-resistant active ulcerative colitis - A study of infliximab administration method for tacrolimus-resistant active ulcerative colitis
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients applied to the medically contraindicated of infliximab Patients during pregnancy Patients are taking concomitant any other biological therapies or cyclosporine Patients are determined to be inappropriate for administration of infliximab by doctors
研究者
相似试验
已完成
2 期
Infliximab effectiveness in COVID-19 patientsIRCT20201229049873N1Shahre-kord University of Medical Sciences40
已完成
不适用
Prospective research of infliximab treatment in active RA patients refractry to anti-interleukin six receptor monoclonal antibody.rheumatoid arthritisJPRN-UMIN000007432Keio University100
进行中（未招募）
不适用
Infliximab dosing based on blood concentrations in patients with sarcoidosis: smart dosingSarcoidosisEUCTR2014-002224-26-NLSt. Antonius Hospital
撤回
4 期
A new dosing strategy of infliximab versus standard dosing in patients with severe sarcoidosis: optimization of treatment1002766510024967SarcoidosisNL-OMON42033Sint Antonius Ziekenhuis70
招募中
2 期
The feasibility study of accelated infliximab infusion from initial administratiopatient in whom infliximab is indicated(rheumatoid arthritis, Crohn's disease, Ulcerative colitis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis)JPRN-UMIN000015297Chiba University Hospital54